Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aclaris Therapeutics (ACRS) Change in Inventory (2018 - 2019)

Aclaris Therapeutics (ACRS) has 2 years of Change in Inventory data on record, last reported at -$3000.0 in Q4 2019.

  • For Q4 2019, Change in Inventory rose 99.74% year-over-year to -$3000.0; the TTM value through Dec 2019 reached -$605000.0, changed N/A, while the annual FY2019 figure was -$605000.0, 493.14% down from the prior year.
  • Change in Inventory reached -$3000.0 in Q4 2019 per ACRS's latest filing, down from $4000.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $65000.0 in Q1 2019 and bottomed at -$1.1 million in Q4 2018.